Dr. Genhong Cheng is a Professor in the Department of Microbiology, Immunology & Molecular Genetics at UCLA. He earned his Ph.D. in molecular biology from the Albert Einstein School of Medicine in 1990. Dr. Cheng joined UCLA’s faculty in 1996, and his research focuses on infection, immunity, cancer, and metabolism. He pioneered TLR-mediated IFN induction pathways, discovering TRAF3 and TANK, and identified an IFN-mediated anti-inflammatory gene program. His research on antiviral IFN stimulatory genes led to novel antiviral strategies against viruses like SARS-CoV-2, Ebola, and Zika. Cheng has published over 230 papers, received several awards, and was elected a Fellow of the AAAS in 2012 and a member of the American Academy of Microbiology in 2018.